DNA · Ginkgo Bioworks Holdings, Inc. · Share Buybacks
$8.55
-1.06 (-11.06%)
At close · Nov 16
Return incl. dividend (before tax)
Play latest call
Q3 2026 earnings call transcript
Market Cap
$622.97M
Shares
64.83M
Volume · Nov 16
1.57M
Avg daily vol (3M)
2.41M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Share-repurchase activity from the company's own XBRL filings — cash spent buying back common stock per fiscal year and per recent quarter, share counts where the company tagged them, and the buyback program's authorization — paired with the company's at-the-market (ATM) equity offering programs, the dilution side of the same picture. Repurchase amounts come exclusively from tagged SEC data; program figures with no tagged equivalent (untagged authorizations and all ATM figures) are read from the filing's own text and shown only after verification.
Remaining Authorization
0 shares
as of 2021-12-31
· not restated in filings since 2022-03-29
Equity Offering (ATM) Programs
| Program Established | Last Amended | Capacity | Remaining | Runs Through | Source |
|---|---|---|---|---|---|
| 2025-09-04 | — | $100,000,000 | — | — | 10-Q , filed 2026-11-09 |
Repurchase History
| Fiscal Year Ended | Cash Spent | Source |
|---|---|---|
| 2019-12-31 | $408,000 | 10-K, filed 2022-03-29 |
Key facts
CIK
1830214
CUSIP
37611X209
13F (30d)
152 filings
116 filers
Visit website
Investor relations